Christopher Pierce
Analyst
Needham
Analyst
Needham & Company
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Needham
Analyst
Source not stated
Current -
Needham & Company
Analyst
Source not stated
Current -
Prelude Therapeutics Inc (PRLD)
Proxy statement
Start not stated–2021-09-30
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2020 | Prelude Therapeutics Inc (PRLD) | M.B.A. Executive Vice President andChief of Business Operations | $204,029 | $3,930,865 |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.